{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:14Z","timestamp":1786112774271,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>With the continuous progress of science and technology, remarkable achievements have been made in the treatment of gastric cancer (GC). In China, the vast majority of GC patients are diagnosed with advanced GC at the time of initial detection. Given its high incidence and mortality rates, GC poses a serious threat to the health of the Chinese population. The selection of appropriate treatment strategies for patients with advanced GC remains a controversial and challenging issue in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>Two patients diagnosed with advanced GC experienced drastically different prognoses due to the adoption of disparate treatment modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>One patient, at stage IIIA, another patient at stage IIB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The stage IIIA patient received neoadjuvant chemotherapy followed by surgical resection, and the stage IIB patient underwent direct surgical resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient who received neoadjuvant therapy and surgery has remained free of recurrence so far. In contrast, the direct surgery one unfortunately succumbed to tumor recurrence 1 year after the operation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>These 2 patients with the same diagnosis of advanced GC presented strikingly different outcomes, which prompted us to deeply contemplate the optimal treatment approaches for this disease. This paper aims to provide valuable references for the treatment selection of advanced GC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048628","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:02:56Z","timestamp":1778745776000},"page":"e48628","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Does the treatment concept of advanced gastric cancer require innovation?: Two cases of advanced gastric cancer with distinctively different outcomes"],"prefix":"10.1097","volume":"105","author":[{"given":"Meifeng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Outpatient Clinic, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangren","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Outpatient Clinic, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China"},{"name":"Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Outpatient Clinic, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China"},{"name":"Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R3-20260805","first-page":"115","article-title":"Cancer statistics in China, 2015.","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/cancers11030399","article-title":"Perioperative treatment in resectable gastric cancer: current perspectives and future directions.","volume":"11","author":"Petrillo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/1097-0142(19821115)50:10<1979::AID-CNCR2820501002>3.0.CO;2-D","article-title":"Clinical cancer research: an embattled species.","volume":"50","author":"Frei","year":"1982","journal-title":"Cancer"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/S1470-2045(17)30321-2","article-title":"Neoadjuvant chemotherapy: survival benefit in gastric cancer.","volume":"18","author":"Das","year":"2017","journal-title":"Lancet Oncol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","article-title":"Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial.","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0360-3016(98)00280-6","article-title":"Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)-report on 370 patients.","volume":"42","author":"Zhang","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.","volume":"29","author":"Ychou","year":"2011","journal-title":"J Clin Oncol"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejca.2020.02.013","article-title":"Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: a single-arm, open-label, phase II trial.","volume":"130","author":"Zheng","year":"2020","journal-title":"Eur J Cancer"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/curroncol29030131","article-title":"Immunotherapy in gastric cancer.","volume":"29","author":"H\u00f6gner","year":"2022","journal-title":"Curr Oncol"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejca.2022.08.023","article-title":"Recent progress and current challenges of immunotherapy in advanced\/metastatic esophagogastric adenocarcinoma.","volume":"176","author":"Moehler","year":"2022","journal-title":"Eur J Cancer"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41467-023-44309-5","article-title":"Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial.","volume":"15","author":"Lin","year":"2024","journal-title":"Nat Commun"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:01:26Z","timestamp":1785945686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":14,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048628","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2025-07-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}